Chutes & Ladders—20-year Novo vet lands first CEO role
In an effort to maximize the earnings potential of its plaque psoriasis cream, Danish dermatology biotech MC2 Therapeutics has hired a former GLP-1 leader to steer the ship. Trine Ahlgreen is the new CEO of MC2, replacing founding CEO Jesper Lange in a planned transition.
Response to Cho et. al’s “GLP-1 Receptor Agonist Use Is Associated with Increased Rates of Acne Vulgaris Diagnosis In Non-Diabetic Obese Women but Not Men: A Retrospective Cohort Study”
Post Content
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best–known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous with a booming weight loss drug market that could hit $139 billion by 2030. Read more…
How Ozempic maker Novo Nordisk fell behind Eli Lilly in the weight loss drug race
Novo Nordisk (NVO) makes Ozempic, the best-known GLP-1 drug out today. And until quite recently, the Danish pharma giant consistently led the pack in new prescriptions, becoming virtually synonymous with a booming weight loss drug market that could hit $139 billion by 2030.Read more…
AgelessRx Broadens GLP-1 Weight Care Options to Advance Longevity-First Healthcare
ANN ARBOR, Mich.–(BUSINESS WIRE)–AgelessRx, a pioneer in longevity and telehealth solutions, is expanding its suite of GLP-1 offerings to better serve customers seeking sustainable, medically guided solutions. The updated offering includes access to Zepbound® via LillyDirect® and the introduction of Compounded Liraglutide + B12. This expansion reflects AgelessRx’s mission to make science-backed, personalized longevity care […]
Could protein bars be the next GLP-1?
Could collagen prove a side effect-free alternative to weight-loss drugs like GLP-1?
Novo Opposes Pharma Tariffs, Urges Crackdown on Illicit Chinese Semaglutide
In a letter to the Department of Commerce, Novo Nordisk argued that unsanctioned compounded semaglutide, mostly from China, constitutes a national security threat to the U.S.
Novo Nordisk Partners with Telehealth for Wegovy Promotion
May 23, 2025Stat + by Katie Palmer https://ro.co/ https://lifemd.com/ Stat + reports on the evolving landscape of GLP-1 drug marketing, noting a shift in the relationship between major pharmaceutical companies like Novo Nordisk and telehealth providers. After previously battling telehealth companies offering compounded versions of their drugs, Novo Nordisk is now collaborating with specific telehealth platforms, including Ro and LifeMD. This partnership […]
Factors associated with weight loss response to GLP-1 analogues for obesity treatment: a retrospective cohort analysis
submitted by /u/PlayfulReputation112 [link] [comments]
Massive Study Of 215,000+ Ozempic Users Reveal Incredible Benefits Beyond Weight Loss
Shutterstock Few drugs in history have gone from initial approval to being a household name faster than the various GLP-1 drugs, including Ozempic and Wegovy. Maybe this isn’t surprising because they are known to be very effective for something that millions of people struggle with everyday. Weight loss. Many people who are on Ozempic or […]